4.6 Article

Kappa opioid receptor endocytosis by dynorphin peptides

期刊

DNA AND CELL BIOLOGY
卷 19, 期 1, 页码 19-27

出版社

MARY ANN LIEBERT INC PUBL
DOI: 10.1089/104454900314672

关键词

-

资金

  1. NIDA NIH HHS [DA 05885, DA 08863] Funding Source: Medline
  2. NINDS NIH HHS [NS 01788] Funding Source: Medline
  3. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K04NS001788] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE ON DRUG ABUSE [F31DA005885, R01DA008863, R56DA008863] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Internalization and downregulation are important steps in the modulation of receptor function. Recent work with the beta(2) adrenergic and opioid receptors have implicated these processes in receptor-mediated activation of mitogen-activated protein kinase (MAPK). We have used CHO cells expressing epitope-tagged rat kappa opioid receptors (rKORs) and prodynorphin-derived peptides to characterize the agonist-mediated endocytosis of rKORs and activation of MAPK. Kappa receptor-selective peptides induced receptor internalization and downregulation whereas nonpeptide agonists did not. An examination of the ability of dynorphin A-17-related peptides (lacking C-terminal amino acids) to promote KOR internalization, inhibition of adenylyl cyclase, and MAPK phosphorylation revealed that the N-terminal seven residues play an important role in eliciting these responses. Both dynorphin peptides and nonpeptide agonists induced rapid and robust phosphorylation of MAPKs. Taken together, these results point to a difference in the ability of dynorphin peptides and nonpeptide ligands to promote rKOR endocytosis and support the view that rKOR internalization is not required for MAPK activation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据